argonautms.com
Selecting the Right CDMO Partner – Three Keys to Success - Argonaut Manufacturing
Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With various competing Contract Development and Manufacturing Organizations (CDMOs) available, selecting the right CDMO partner for your business can be difficult. You should look for a CDMO that: Uses state-of-the-art equipment and can meet your manufacturing capacity needs. Adheres to international regulatory standards. Works flexibly with you as a partner. How can you differentiate between an optimal CDMO partner and a pitfall? Here are the three key areas to consider when selecting your drug product manufacturing partner. 1. Capabilities, Capacity, and Technology With drug manufacturing outsourcing penetration expected to soar from 30% in 2018 to 40% in 2020, CDMO capacity will be in greater demand. As personalized medicine drives more discovery-based and virtual companies without in-house capabilities to come online, demand for API manufacturing and fill-finish activity will continue to increase. Limited CDMO capacity is already a chief complaint among pharmaceutical board members that outsource their manufacturing. Be sure to select a drug product manufacturing partner that has capacity to support your projects not only now, but also in the future. CDMOs with equipment built for fast turnover will have greater flexibility and production capacity. This need for availability extends beyond just production; look for a CDMO with an efficient tech transfer process and the ability to support your quality control testing needs. Not all fill-finish lines are created equal. While drug …